Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: BLA 2.
| Dosage form | NDCs |
|---|---|
| solution | 2 |
| Route | NDCs |
|---|---|
| intravenous | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| bpl | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ALBUMINEX | Albumin Human | solution, intravenous | 64208-2510BLA |
| ALBUMINEX | Albumin Human | solution, intravenous | 64208-2512BLA |
Compare
Other companies listing albumin human
- Takeda Pharmaceuticals U.S.A., Inc.7 sites · 226 NDC
- Octapharma USA Inc0 sites · 24 NDC
Enquiry
Common questions
- Is BPL FDA approved?
- BPL holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does BPL make?
- 2 products are listed under BPL in the openFDA NDC Directory, most often as solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.